Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
50T |
| CAT No. |
130617503M |
| Application |
Autoimmune |
The MAGLUMI ANA Screen (CLIA) is a high-performance chemiluminescent immunoassay (CLIA) kit designed for the qualitative detection of Anti-Nuclear Antibodies (ANA) in human serum. It is optimized for use on the MAGLUMI automated immunoassay analyzers, ensuring accurate, reliable, and fast results for autoimmune disease screening
Unmatched Detection PrecisionLeveraging chemiluminescence immunoassay technology, the MAGLUMI ANA Screen achieves high sensitivity and specificity when identifying Autoimmune Disease markers. The advanced chemistry enhances detection rates, providing dependable results for clinical assessments. Its seamless integration with MAGLUMI CLIA analyzers streamlines workflows, ensuring laboratories deliver accurate data swiftly.
Comprehensive UsabilityDesigned for versatility, this test kit is ideal for laboratories, healthcare dealers, distributors, exporters, and other suppliers across India. Whether used in specialized diagnostic centers or large-scale facilities, it brings efficiency and consistency. The process is optimized for laboratory use, requiring standard handling procedures and supporting robust diagnostic needs.
FAQ's of MAGLUMI ANA Screen (CLIA):
Q: How is the MAGLUMI ANA Screen (CLIA) used in the laboratory?
A: The MAGLUMI ANA Screen (CLIA) is utilized with compatible MAGLUMI CLIA analyzers, where the chemiluminescent reagents are loaded, and patient serum samples are processed automatically to detect Anti-Nuclear Antibodies, aiding in autoimmune disorder screening.
Q: What makes chemiluminescence immunoassay advantageous for ANA screening?
A: Chemiluminescence immunoassays offer enhanced sensitivity and rapid signal generation, allowing for precise and reliable detection of Autoimmune markers, which is critical for accurate ANA screening in clinical diagnostics.
Q: When should the MAGLUMI ANA Screen (CLIA) be used?
A: This test is typically used during the investigation of suspected autoimmune diseases, assisting clinicians in diagnosing connective tissue and other systemic autoimmune disorders by identifying Anti-Nuclear Antibodies in patient samples.
Q: Where can the MAGLUMI ANA Screen (CLIA) be sourced in India?
A: The kit is available through authorized laboratories, dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers across India, ensuring wide accessibility for medical institutions and diagnostic centers.
Q: What is the process for storing the MAGLUMI ANA Screen (CLIA) reagents?
A: It is essential to store the reagents at a controlled temperature range of 2C to 8C to preserve their efficacy, prevent degradation, and ensure the reliability of diagnostic results.
Q: What are the primary benefits of using the MAGLUMI ANA Screen (CLIA)?
A: The main benefits include high accuracy, rapid turnaround time, and streamlined compatibility with MAGLUMI CLIA analyzers, making it ideal for high-throughput laboratories and comprehensive autoimmune disease screening.